| Application no. and date | 18794202.4 (espacenet) (Federated) (European Patent Register), 20180503 | | Patent/reg. no. and date | DK/EP 3628049, 20230510 | | Publication date | 20200401 | | Priority no. and date | US 201762501229 P, 20170504, US 201762510422 P, 20170524, US 201762578674 P, 20171030 | | EP pub. no. and date |
EP 3628049 20200401 | | Effective date | | | Applicant/owner | Acceleron Pharma Inc., 128 Sidney Street
Cambridge, MA 02139, US | | Applicant ref. no. | PU278975DKQ | | Inventor | KUMAR, Ravindra, 421 Arlington Street
Acton, MA 01720, US,
Sako, Dianne S., 14 Mystic Street
Medford, MA 02155, US | | Representative | Marks & Clerk LLP, 44 rue de la Vallée
BP 1775
L-1017 Luxembourg, LU | | Opponent | | | IPC Class | A61K 38/17 (2006.01) , A61P 13/12 (2006.01) , A61P 35/00 (2006.01) , A61P 9/10 (2006.01) , A61P 9/12 (2006.01) , C07K 14/71 (2006.01) , C07K 16/46 (2006.01) | | Title | TGF-BETA-RECEPTORTYPE-II-FUSIONSPROTEINER OG ANVENDELSER DERAF | | Int. application no. | US2018030816 | | Int. publication no. | WO2018204594 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
